A Scoring System to Optimize Pioglitazone Therapy after Stroke Based on Fracture Risk

BACKGROUND AND PURPOSE: The insulin sensitizer, pioglitazone, reduces cardiovascular risk in patients after an ischemic stroke or TIA but increases bone fracture risk. We conducted a secondary analysis of the Insulin Resistance Intervention after Stroke (IRIS) trial to assess the effect of pre-treat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Stroke
Prif Awduron: Viscoli, Catherine M., Kent, David M., Conwit, Robin, Dearborn, Jennifer L., Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Stuart, Amber, Young, Lawrence H., Kernan, Walter N.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557695/
https://ncbi.nlm.nih.gov/pubmed/30580725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.022745
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg